What is the appropriate management for a patient with jaundice and symptoms of infectious mononucleosis?

Management of Jaundice with Infectious Mononucleosis

In a patient presenting with jaundice and symptoms of infectious mononucleosis, provide supportive care only, as EBV-related hepatitis is typically self-limiting and does not require antiviral or immunosuppressive therapy, even when jaundice is severe or prolonged. 1, 2

Confirm the Diagnosis

Clinical Recognition

• The classic triad of infectious mononucleosis consists of fever, tonsillar pharyngitis, and posterior cervical lymphadenopathy 3, 2
• Hepatomegaly occurs in approximately 10% of cases and may be tender on examination 3
• Splenomegaly is present in approximately 50% of cases 3
• Periorbital or palpebral edema (typically bilateral) occurs in one-third of patients 3

Laboratory Confirmation

• Order a complete blood count with differential showing >40% lymphocytes and >10% atypical lymphocytes 2
• Perform a rapid heterophile antibody test (monospot), which has 87% sensitivity and 91% specificity 2
• If the heterophile test is negative but clinical suspicion remains high, order EBV viral capsid antigen (VCA) antibody testing: IgM-VCA indicates acute infection, while IgG-VCA with absent EBNA antibodies confirms recent infection 4
• Elevated liver enzymes (transaminases) increase clinical suspicion for infectious mononucleosis when the heterophile test is negative 2

Assess Severity of Hepatic Involvement

Laboratory Evaluation for Jaundice

• Obtain fractionated bilirubin to determine if hyperbilirubinemia is conjugated or unconjugated 5, 6
• Check hepatic function panel including AST, ALT, alkaline phosphatase, and GGT 5
• Measure albumin and coagulation studies (PT/INR) to assess synthetic function 5

Imaging

• Perform abdominal ultrasound as the initial imaging modality to exclude biliary obstruction and assess for hepatomegaly 5, 6
• Ultrasound may show hepatomegaly and gallbladder wall thickening, which are predictors of significant EBV liver involvement 1

Red Flags Requiring Urgent Intervention

• Coagulopathy with INR >1.5 indicates acute liver failure and requires immediate hepatology consultation 5
• Encephalopathy combined with jaundice suggests fulminant hepatic failure 5
• Fever with jaundice requires blood and urine cultures to exclude cholangitis or sepsis 5

Provide Supportive Management

Conservative Approach

• Treatment is entirely supportive; routine use of antivirals and corticosteroids is not recommended 2
• Even in cases with multiple transaminase peaks or prolonged hepatitis lasting 11+ weeks, conservative management without antiviral or immunosuppressive therapy is appropriate for immunocompetent patients 1
• Recommend activity reduction and bed rest as tolerated 3

Activity Restrictions

• Advise patients to avoid contact sports and strenuous exercise for 8 weeks from symptom onset or while splenomegaly persists 3
• This restriction prevents splenic rupture, which occurs in 0.1-0.5% of cases and is the most feared complication 3, 2
• Use shared decision-making to determine exact timing of return to athletic activity 2

Anticipate Clinical Course

Expected Pattern

• EBV-related hepatitis is typically mild and self-limiting 1
• Transaminases may show multiple peaks corresponding with clinical deterioration, but this does not indicate need for specific therapy 1
• Peak ALT levels can reach >1,700 U/L and total bilirubin >150 µmol/L, yet full recovery occurs with conservative management 1
• Fatigue may be profound but tends to resolve within three months 3

Cholestatic Jaundice Variant

• Severe cholestatic jaundice can occur, particularly in elderly patients, mimicking extrahepatic biliary obstruction 7
• This presentation may lead to diagnostic delay and unnecessary invasive procedures if EBV is not considered 7
• Despite severe cholestasis, the condition remains self-limited 7

Common Pitfalls to Avoid

• Do not initiate antiviral therapy based solely on elevated transaminases or multiple enzyme peaks 1
• Do not assume biliary obstruction from malignancy without considering EBV in the differential diagnosis of cholestatic jaundice 7
• Do not overlook the heterophile antibody test's potential for false-negative results in children <5 years and adults during the first week of illness 2
• Do not allow patients to return to contact sports before 8 weeks or while splenomegaly persists, regardless of symptom improvement 3

Monitor for Complications

• Infectious mononucleosis is a risk factor for chronic fatigue syndrome 3
• Immunosuppressed populations are at higher risk of severe disease and significant morbidity 2
• Long-term, EBV infection has been linked to Hodgkin lymphoma, non-Hodgkin lymphoma, and nasopharyngeal carcinoma 2